N (6)‐methyladenosine‐binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay TL Xia, X Li, X Wang, YJ Zhu, H Zhang, W Cheng, ML Chen, Y Ye, Y Li, ... EMBO reports 22 (4), e50128, 2021 | 84 | 2021 |
Harnessing and enhancing macrophage phagocytosis for cancer therapy S Chen, SWT Lai, CE Brown, M Feng Frontiers in Immunology 12, 635173, 2021 | 82 | 2021 |
Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer X Cao, B Li, J Chen, J Dang, S Chen, EG Gunes, B Xu, L Tian, S Muend, ... Journal for ImmunoTherapy of Cancer 9 (3), 2021 | 71 | 2021 |
Bispecific antibodies in cancer immunotherapy S Chen, J Li, Q Li, Z Wang Human vaccines & immunotherapeutics 12 (10), 2491-2500, 2016 | 65 | 2016 |
Mechanistic studies for the role of cellular nucleic-acid-binding protein (CNBP) in regulation of c-myc transcription S Chen, L Su, J Qiu, N Xiao, J Lin, J Tan, T Ou, L Gu, Z Huang, D Li Biochimica et Biophysica Acta (BBA)-General Subjects 1830 (10), 4769-4777, 2013 | 61 | 2013 |
Tumor cell-secreted ISG15 promotes tumor cell migration and immune suppression by inducing the macrophage M2-like phenotype RH Chen, ZW Xiao, XQ Yan, P Han, FY Liang, JY Wang, ST Yu, TZ Zhang, ... Frontiers in Immunology 11, 594775, 2020 | 60 | 2020 |
Warburg effect is a cancer immune evasion mechanism against macrophage immunosurveillance J Chen, X Cao, B Li, Z Zhao, S Chen, SWT Lai, SA Muend, GK Nossa, ... Frontiers in immunology 11, 621757, 2021 | 36 | 2021 |
Single domain antibody-based bispecific antibody induces potent specific anti-tumor activity J Li, C Zhou, B Dong, H Zhong, S Chen, Q Li, Z Wang Cancer Biology & Therapy 17 (12), 1231-1239, 2016 | 34 | 2016 |
A novel bispecific antibody, BiSS, with potent anti-cancer activities B Dong, C Zhou, P He, J Li, S Chen, J Miao, Q Li, Z Wang Cancer biology & therapy 17 (4), 364-370, 2016 | 34 | 2016 |
Interaction of Berberine derivative with protein POT1 affect telomere function in cancer cells N Xiao, S Chen, Y Ma, J Qiu, JH Tan, TM Ou, LQ Gu, ZS Huang, D Li Biochemical and Biophysical Research Communications 419 (3), 567-572, 2012 | 32 | 2012 |
A novel bispecific antibody, S-Fab, induces potent cancer cell killing L Li, P He, C Zhou, L Jing, B Dong, S Chen, N Zhang, Y Liu, J Miao, ... Journal of Immunotherapy 38 (9), 350-356, 2015 | 30 | 2015 |
A targeted IL-15 fusion protein with potent anti-tumor activity S Chen, Q Huang, J Liu, J Xing, N Zhang, Y Liu, Z Wang, Q Li Cancer biology & therapy 16 (9), 1415-1421, 2015 | 25 | 2015 |
Cellular nucleic acid binding protein suppresses tumor cell metastasis and induces tumor cell death by downregulating heterogeneous ribonucleoprotein K in fibrosarcoma cells J Qiu, S Chen, L Su, J Liu, N Xiao, TM Ou, JH Tan, LQ Gu, ZS Huang, D Li Biochimica et Biophysica Acta (BBA)-General Subjects 1840 (7), 2244-2252, 2014 | 25 | 2014 |
Cobalt chloride-induced hypoxia induces epithelial-mesenchymal transition in renal carcinoma cell lines N Zhang, B Hong, C Zhou, X Du, S Chen, X Deng, S Duoerkun, Q Li, ... Annals of Clinical & Laboratory Science 47 (1), 40-46, 2017 | 21 | 2017 |
Targeting tumor-associated macrophages for cancer immunotherapy X Cao, SWT Lai, S Chen, S Wang, M Feng International Review of Cell and Molecular Biology 368, 61-108, 2022 | 16 | 2022 |
A Single Domain–Based Anti-Her2 Antibody Has Potent Antitumor Activities X Wu, S Chen, L Lin, J Liu, Y Wang, Y Li, Q Li, Z Wang Translational oncology 11 (2), 366-373, 2018 | 16 | 2018 |
Pro-phagocytic function and structural basis of GPR84 signaling X Zhang, Y Wang, S Supekar, X Cao, J Zhou, J Dang, S Chen, L Jenkins, ... Nature Communications 14 (1), 5706, 2023 | 12 | 2023 |
UHRF1 controls thymocyte fate decisions through the epigenetic regulation of EGR1 expression Y Zhang, Y Chen, R Ma, Y Jiang, J Liu, Y Lin, S Chen, M Xia, F Zou, ... The Journal of Immunology 204 (12), 3248-3261, 2020 | 11 | 2020 |
Prodrug AST-003 improves the therapeutic index of the multi-targeted tyrosine kinase inhibitor sunitinib Q Huang, C Zhou, X Chen, B Dong, S Chen, N Zhang, Y Liu, A Li, M Yao, ... PloS one 10 (10), e0141395, 2015 | 10 | 2015 |
Non‐Steroidal Anti‐Inflammatory Drugs (NSAIDs) sensitize melanoma cells to MEK inhibition and inhibit metastasis and relapse by inducing degradation of AXL Y Chen, Y Zhang, S Chen, W Liu, Y Lin, H Zhang, F Yu Pigment Cell & Melanoma Research 35 (2), 238-251, 2022 | 8 | 2022 |